The EBV-Encoded dUTPase Activates NF-κB through the TLR2 and MyD88-Dependent Signaling Pathway

Abstract

The innate immune response plays a key role as the primary host defense against invading pathogens including viruses. We have previously shown that treatment of human monocyte-derived macrophages with EBV-encoded dUTPase induces the expression of proinflammatory cytokines through the activation of NF-κB. However, the receptor responsible for EBV-encoded dUTPase-mediated biological effects is not known. In this study, we demonstrate that the purified EBV-encoded dUTPase activates NF-κB in a dose-dependent manner through TLR2 and requires the recruitment of the adaptor molecule MyD88 but not CD14. Furthermore, activation of NF-κB was abrogated by anti-TLR2, anti-EBV-encoded dUTPase blocking Abs and the overexpression of a dominant negative construct of MyD88 in human embryonic kidney 293 cells expressing TLR2. In addition, treatment of human monocyte-derived macrophages with the anti-EBV-encoded dUTPase Ab 7D6 or the anti-TLR2 Ab blocked the production of IL-6 by the EBV-encoded dUTPase. To our knowledge, this is the first report demonstrating that a nonstructural protein encoded by EBV is a pathogen-associated molecular pattern and that it has immunomodulatory functions. Although additional studies are necessary to define the signaling pathways activated by the EBV-encoded dUTPase and to determine its role in modulating immune responses to EBV infection, our results suggest that the dUTPase could be a potential target for the development of novel therapeutic agents against infections caused by EBV.

EBV Latent Membrane Protein 1 Is a Negative Regulator of TLR9

“…2). Interestingly, it has recently been shown that the nonstructural EBV protein, dUTPase, is recognized by TLR2, leading to NF-kB activation (36). It is thus not surprising that we have observed that the virus efficiently downregulates both TLR2 and TLR9 mRNA, as both receptors are activated by two distinct EBV components, similarly to HSV-2 (37).…”

Epstein-Barr Virus Deubiquitinase Downregulates TRAF6-Mediated NF-κB Signaling during Productive Replication

“…It is reported that EBV BILF1 and BLLF3 proteins expressed in later stages of lytic replication again upregulate NF-B signaling (80,81). EBV G-protein-coupled receptor (EBV BILF1) also appeared to activate the NF-B pathway in COS-7 and Burkitt's lymphoma cells (82).…”

TLR2 Stimulation Regulates the Balance between Regulatory T Cell and Th17 Function: A Novel Mechanism of Reduced Regulatory T Cell Function in Multiple Sclerosis

“…Respiratory viruses that can activate TLR2 (29,63) also have been associated with MS exacerbations (31,32,61). In addition, EBV, which is strongly associated with MS susceptibility (30), is able to activate the transcription factor NF-kB and the production of the chemokine CCL2 in a TLR2-dependent manner (65,66).…”